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through 1) the similar antibody used in the G1/G2 ELISA assay,
F-78, binding to a repetitive epitope exposed twice on G1 and G2
or, 2) by BC-3 detecting the aggrecanase-generated N-terminal
374ARGSVI sequence.
Results: Induction of cartilage degradation ex vivo, resulted in 10
fold elevated aggrecanase fragments (374ARGSVI-G2) (P=0.02)
and 9 fold increased total aggrecan release (G1/G2) (P=0.02),
compared to that of vehicle control. Total aggrecan levels in
RA patients were signiﬁcantly decreased from 824.8±31 ng/ml
in healthy controls to 570.5±30 ng/ml, corresponding to an
approximate 31% decrease (P<0.0001). Western blot analysis
for total aggrecan showed one strong band detected at 10 kDa,
and weaker bands at 25 and 45 kDa in both healthy controls
and RA patients. With regards to aggrecanase activity, only one
strong band in RA patients of 45 kDa was detected.
Conclusions: This study is the ﬁrst to characterize different
aggrecan fragments in human serum. We clearly demonstrate
that total aggrecan levels are lowered in RA patients. In align-
ment, RA patients had highly elevated aggrecanase-mediated
aggrecan degradation, providing a rationale for the decreased
aggrecan levels. These data may provide a new diagnostic tool
for monitoring joint-destruction in RA patients, and allow for early
assessment of response to treatment prior to that of traditional
radiographic techniques.
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CHARACTERIZATIONOF METALLOPROTEINASE
CLEAVAGE PRODUCTS OF HUMAN ARTICULAR
CARTILAGE
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P.G. Mitchell2, K.L. Dufﬁn1
1Eli Lilly and Company, Greenﬁeld, IN; 2Eli Lilly and Company,
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Purpose: The present study measures the effects of metallopro-
teases on human articular cartilage. Supernatants from diges-
tions with these enzymes were analyzed via proteomics methods
to characterize post-translational modiﬁcations of cartilage pep-
tides, to determine speciﬁc cartilage protein cleavage sites of
different metalloproteases to better understand their selectivities,
and to measure release of peptides that may serve as useful
biomarkers of cartilage degradation. The metalloproteases uti-
lized in this study have been reported to be overexpressed and
active in arthritic cartilage, so determination of their substrates
and products may lead to a better understanding of their po-
tential role in disease and to identiﬁcation of new targets and
biomarkers of cartilage degradation.
Methods: Human articular cartilage was digested by addition
of exogenous metalloproteases, including MMP-2, -3, -8, -9, -
12, -13, ADAMTS-4, and ADAMTS-5, and proteolyzed peptide
products were identiﬁed by proteomics methods using mass
spectrometry.
Results: Complete sequences of peptides, including N- and
C-termini and post-translational modiﬁcations were determined.
Abundant peptides originating from collagen types I, II, and III,
biglycan, prolargin, ﬁbromodulin, ﬁbronectin, decorin, cartilage
oligomeric matrix protein, cartilage intermediate layer protein,
megakaryocyte stimulating factor, mimecan, aggrecan, and lu-
mican were identiﬁed after metalloprotease digestion. Speciﬁc
collagen type II peptide biomarkers, including those containing
the 3/4 – 1/4 cleavage site and those containing the Helix-II
and CTX-II domains, were observed after release by selected
proteases.
Conclusions: this study identiﬁes many of the most abundant
metalloprotease cleavage products of human articular cartilage.
The list of peptides generated by these digestions provides in-
sights into the broad number of substrates susceptible to speciﬁc
metalloprotease proteolysis in diseased cartilage. Many of these
peptides are potential biomarkers of arthritis or of metallopro-
tease activity in articular cartilage. Further evaluation of many of
these peptides as biomarkers might be achieved by quantitation
in synovial ﬂuid, blood, or urine.
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EFFECTS OF EXERCISE AND OSTEOCHONDRAL
INJURY ON CTX II CONCENTRATIONS IN EQUINE
SYNOVIAL FLUID AND SERUM
O.B. Cleary, T.N. Trumble, M.P. Brown, K.A. Merritt
University of Florida, Gainesville, FL
Purpose: Collagen type II is the predominant collagen in articular
cartilage and is highly speciﬁc for this tissue. A biomarker of
crosslinked C-telopeptide fragments of type II collagen (CTX II)
has been used to assess severity and progression of cartilage
degradation in humans. The objectives of the current study were
to evaluate the effects of exercise and osteochondral (OC) injury
on concentrations of CTX II fragments in synovial ﬂuid (SF) and
serum of horses.
Methods: SF and serum samples were taken from 3 groups of
Thoroughbred racehorses: (1) rested horses (n=40), (2) exer-
cised horses: group 1 horses had the same joints sampled after
4-7 months of race training (n=40) and (3) OC injured horses:
racehorses that had arthroscopic surgery for removal of OC frag-
ments resulting from racing injury (n=44). From group 1 and 2
horses, SF was obtained from 20 metacarpophalangeal (MCP),
Figure 1. Comparison of SF to serum CTX II concentrations (SF:serum) in
rested, exercised, and OC injured horses. A. MCJ - middle carpal joint; B. RCJ
- radiocarpal joint; C. MCP/MTP - metacarpophalangeal/metatarsophalangeal
joint.
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10 middle carpal (MCJ), and 10 radiocarpal (RCJ) joints (n=40).
SF samples from group 3 horses were from 16 MCP, 6 metatar-
sophalangeal (MTP), 12 MCJ, and 10 RCJ (n= 44). Serum
CTX II was measured for all horses (n=124). SF and serum
CTX II concentrations were measured by an ELISA (Pre-Clinical
CartiLaps®) previously validated for use in equine serum and SF.
Differences between groups in serum and SF CTX II concen-
trations and the ratio (SF:serum) were evaluated using one-way
ANOVA with Tukey’s test for multiple pairwise comparisons. P <
0.05 was considered signiﬁcant.
Results: Concentrations of CTX II were signiﬁcantly elevated
in SF from all joints of horses with osteochondral fragmentation
compared to rested (P<0.05). Concentrations of CTX II were
signiﬁcantly elevated in SF from MCP/MTP and RCJ of horses
with osteochondral fragmentation compared to exercised horses
(P<0.05). There was no signiﬁcant difference in SF CTX II be-
tween rested and exercised horses for any of the joints analyzed.
Serum CTX II concentrations were signiﬁcantly lower in horses
with OC injury in MCJ and RCJ compared to rested horses
(P<0.01). Horses with MCJ OC injury had signiﬁcantly lower
serum CTX II concentrations than exercised horses (P<0.01),
but horses with RCJ and MCP/MTP OC injury did not. SF to
serum ratios (SF:serum) were signiﬁcantly higher in horses with
MCP/MTP and MCJ OC injury compared to rested and exer-
cised horses (P<0.001) (Fig. 1). A signiﬁcant difference was
found between MCJ and RCJ OC injury SF:serum (P<0.05).
Conclusions: These results strongly support the use of SF and
serum CTX II concentrations as a discriminating biomarker for
the diagnosis of OC injury in equine joints.
Acknowledgements: Study supported by the American College
of Veterinary Surgeons.
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COLL2-1 AND COLL2-1 NO2: MARKERS OF EARLY
DISEASE IN THE HARTLEY GUINEA PIG MODEL OF
SPONTANEOUS OA
J.L. Huebner1, M. Deberg2, Y. Henrotin2, V.B. Kraus1
1Duke Univeristy Medical Center, Durham, NC; 2Bone and
Cartilage Research Unit, University of Liege, Liege, Belgium
Purpose: Several different type II collagen epitopes have been
described as potential biomarkers of onset and/or progression
of OA. Among the degradative markers, the C-telopeptide frag-
ment, CTXII, has the most abundant data supporting its use
as an arthritis marker. More recently, two serum immunoassays
have been developed to quantify a sequence derived from the
triple helical region of type II collagen, (Coll2-1) and its nitrated
form (Coll2-1 NO2), that can be used to quantify both cartilage
degradation as well as oxidative damage, respectively. In this
study, we investigated the utility of serum Coll2-1, Coll2-1 NO2
and CTXII in a well characterized cohort of Hartley guinea pigs.
Methods: Forty six male Hartley guinea pigs were sacriﬁced at
3 weeks, 2, 4, 7, 10, 12 and 18 months of age, at which time
blood samples were obtained. Histological severity of OA was
determined using a semi-quantitative grading scheme described
previously. Serum Coll2-1 and Coll2-1 NO2 were quantiﬁed by
competitive ELISA and serum CTXII were quantiﬁed using the
Serum Pre-clinical Cartilaps ELISA. This assay was designed to
detect degradation products of C-terminal telopeptides of type II
collagen in animal sera. Statistical analyses included: the non-
parametric Mann Whitney test to compare the levels of Coll2-1 at
3 weeks and 4 months of age, and correlations between Coll2-
1 and total histological score estimated by the non-parametric
Spearman’s rank correlation coefﬁcient. Data were considered
statistically signiﬁcant at p value < 0.05.
Results: CTXII and Coll2-1 displayed completely different time
course proﬁles (Fig. 1). At 3 weeks of age, CTXII was elevated
Figure 1
and rapidly declined to very low levels by 7 months of age,
showing very little change from 7-18 months of age. In contrast,
Coll2-1 displayed a nadir at 3 weeks, a 65% increase from 3
weeks to 4 months of age (p=0.002) with consistently elevated
levels thereafter to 18 months of age. The serum proﬁle for Coll2-
1NO2 was similar but concentrations equaled1-2% the serum
concentrations of Coll2-1 throughout the time course. The early
change in Coll2-1 correlated with an increase in OA histological
severity during this time interval (r=0.75, p=0.0004). Mean serum
Coll2-1 was signiﬁcantly different between the lowest quartile of
OA histological severity and the higher three quartiles (Fig. 2).
Figure 2
Conclusions: Although CTXII and Coll2-1 are both type II colla-
gen speciﬁc epitopes, it is clear that they reﬂect different biolog-
ical processes, probably as a result of differential expression of
collagen degradative enzymes in different joint tissue compart-
ments. For instance, the serum CTXII proﬁle in the guinea pig is
most compatible with collagen II turnover in the growth plate car-
tilage which ceases at 4 months of age in this model and is barely
measurable during the period of development of histological OA.
In contrast, the levels of Coll2-1 and Col2-1 NO2 are lowest
during the most active period of growth plate cartilage turnover,
increase markedly in young animals when collagen birefringence
data suggests collagen disruption is occurring, and remain ele-
vated during the course of disease development. These results
suggest that the Coll2-1 and Coll2-1NO2 epitopes are likely gen-
erated from articular cartilage and may be useful as quantitative
biomarker outcomes for early disease prevention and treatment
in this model system.
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BIOMARKERS ASSOCIATED WITH CLINICAL
PHENOTYPES OF HAND OSTEOARTHRITIS IN A LARGE
MULTIGENERATIONALFAMILY: GIAFD FAMILY
H-C. Chen, T. Stabler, V.B. Kraus
Duke University Medical Center, Durham, NC
Purpose: The goal of this study was to evaluate the relation-
ship between biological markers and osteoarthritis (OA) clinical
phenotypes in a large multigenerational family in the United
